Sign in
4

Changes in Ownership

NRC HEALTH Filed Acc 0001140361-18-018958

CEO gave up 1,799 shares (to pay taxes)

  • CEO acquired 4,007 shares (grant or award)
  • CEO returned 137 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hays Michael D. CEO 2018-04-17 Returned to the company −125 0 I: show line 1 in the form
Hays Michael D. CEO 2018-04-17 Grant or award +125 139,095 I: show line 2 in the form
Hays Michael D. CEO 2018-04-17 Returned to the company −12 0 I: show line 3 in the form
Hays Michael D. CEO 2018-04-17 Grant or award +12 87 I: show line 4 in the form
Hays Michael D. CEO 2018-04-17 Grant or award +3,870 3,870 D: show line 5 in the form
Hays Michael D. CEO 2018-04-17 Shares withheld for taxes −1,799 $33.55 $60,356 2,071 D: show line 6 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hays Michael D. CEO 2018-04-17 Returned to the company · Employee Stock Option (right to buy) −2,491 0 D: show line 7 in the form
Hays Michael D. CEO 2018-04-17 Returned to the company · Employee Stock Option (right to buy) −1,823 0 D: show line 8 in the form
Hays Michael D. CEO 2018-04-17 Returned to the company · Employee Stock Option (right to buy) −266 0 D: show line 9 in the form
Hays Michael D. CEO 2018-04-17 Returned to the company · Employee Stock Option (right to buy) −1,669 0 D: show line 10 in the form
Hays Michael D. CEO 2018-04-17 Returned to the company · Employee Stock Option (right to buy) −1,524 0 D: show line 11 in the form
Hays Michael D. CEO 2018-04-17 Returned to the company · Employee Stock Option (right to buy) −1,246 0 D: show line 12 in the form
Loading xslF345X03/doc1.xml…